You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 169 No. 19, October 26, 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Public Health, Other
 •Patient Safety/ Medical Error
 •Statistics and Research Methods
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

HEALTH CARE REFORM
Adverse Events in Randomized Trials

Neglected, Restricted, Distorted, and Silenced

John P. A. Ioannidis, MD

Arch Intern Med. 2009;169(19):1737-1739.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Accurate information on harms of medical interventions is essential for evidence-based practice. Most newly introduced treatments usually have small, incremental benefits, if any, against already available interventions, and differences in the profile of harms should play a key role on treatment choice. Randomized trials offer an excellent opportunity to evaluate harms of interventions using the most robust experimental design available in clinical research. However, several empirical evaluations (Table) have shown that many trials do not report harms or report them in a fragmented or suboptimal way. In this issue, an excellent study by Pitrou et al1 adds more evidence on this issue.


 
Table appears in full text version.
Table. Empirical Studies Evaluating the Reporting of Harms in Randomized Trialsa


Pitrou et al1 evaluated 133 trials published recently in 6 high–impact factor journals. Most previous empirical studies had examined older trials and typically selected articles based on topic; only 2 . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Reporting of Safety Results in Published Reports of Randomized Controlled Trials
Isabelle Pitrou, Isabelle Boutron, Nizar Ahmad, and Philippe Ravaud
Arch Intern Med. 2009;169(19):1756-1761.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.